Close mobile menu×
Close mobile menu

Yoshifumi Naka, MD, PhD

Expertise in: 
Cardiac Surgery, Thoracic and Cardiac Surgery, Surgery, General
Accepting New Patients
Profile Headshot

Appointments

Phone Appointments

New and Existing Patients: 
(212) 305-0828

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

America's Top Doctor
NY Top Doctor

Clinical Expertise

  • Cardiac Surgery
  • Thoracic and Cardiac Surgery
  • Surgery, General
  • Heart Surgery
  • Bloodless Surgery
  • Cardiac Valve Surgery
  • Heart Valve Surgery
  • Aortic Disease
  • Valve Replacement
  • Valve Reconstruction/Repair
  • Thoracic Aneurysm
  • Open Heart Surgery
  • Aortic Aneurysm
  • Pericardial Disease
  • Bicuspid Aortic Valve
  • Marfan's Syndrome
  • Aortic Dissection
  • Cardiac Surgery
  • Minimally Invasive Aneurysm Repair
  • Arterial Insufficiency
  • Cardiac Valve Replacement
  • Mitral Valve Surgery
  • Mitral Valve Prolapse
  • Mitral/Aortic Valve Replacement
  • Aneurysm Repair
  • Minimally Invasive Cardiac Surgery
  • Mechanical Circulatory Support
  • Mitral Valve Repair
  • Off Pump Coronary Bypass Surgery
  • Heart Valve Repair
  • Heart Failure
  • Thoracic/Cardiothoracic Surgery
  • Aneurysm Surgery
  • Coronary Artery Bypass
  • Minimally Invasive Valve Repair
  • Heart Transplantation
  • Thoracic Aneurysm Surgery
  • Aneurysm Aortic Surgery
  • Aneurysm Repair, Aortic

Education & Training

  • Osaka University, Japan
  • BM, 1984 Osaka University Medical School (Japan)
  • Residency: Osaka University Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Honors & Awards

  • New York Magazine's Top Doctors, 2005 - present
  • Socrates Award, 2016
  • Cournand and Comroe Young Investigator Award, American Heart Association, 1995
  • First Prize. Residents Research Prize Competition, College of Physicians and Surgeons of Columbia University, 1994
  • First Prize. Residents Research Prize Competition, College of Physicians and Surgeons of Columbia University, 1995
  • Young Investigators Award, Japanese Association of Thoracic Surgery, 1988

About Yoshifumi Naka

LVAD, Artificial Heart - Dr. Yoshifumi Naka

Yoshifumi Naka, MD, PhD, is an internationally known heart transplant surgeon and a pioneer in mechanical assist therapy for heart failure. Under his leadership, Columbia University Medical Center’s Cardiac Transplantation and Mechanical Circulatory Support Programs have earned international recognition for their contributions in developing and testing new cardiac devices and in training cardiothoracic surgeons around the world. Columbia’s heart transplant program is the largest U.S. heart transplant program by volume.

Dr. Naka’s clinical specialties include adult cardiac surgery for coronary artery disease, valvular heart disease, heart transplantation, and mechanical circulatory support device implantation. His research has focused on cardiac and pulmonary transplantation, organ preservation, surgical treatment of atrial fibrillation, vein graft disease after bypass surgery, and outcomes of clinical mechanical circulatory support device surgery and heart transplantation. He has been a lead investigator in several clinical trials paving the way in the research and innovation of new approaches to mechanical circulatory assistance, including use of these devices as destination therapy for patients with advanced heart failure.

Dr. Naka earned his medical and post-doctoral degrees at the Osaka University Medical School in Japan. Upon his arrival at Columbia University in 1993, he began his specialization in cardiac and pulmonary transplantation, in research efforts. He finished his training in 1998, having completed a research fellowship in cardiac and pulmonary transplantation and a visiting clinical fellowship in cardiothoracic surgery, after which he joined the cardiac surgery faculty of the Columbia University College of Physicians and Surgeons.  

Academic Titles

  • Professor of Surgery

Administrative Positions

  • Director, Cardiac Transplantation Program, NewYork-Presbyterian/Columbia
  • Director, Mechanical Circulatory Support Program

Committee/Societies/Council Memberships

  • American Association for Thoracic Surgery
  • American Heart Association
  • Councils of Circulation and Cardiothoracic Surgery
  • American Society for Artificial Internal Organs
  • American Society of Transplant Surgeons
  • European Society for Cardiothoracic Surgeons
  • International Society for Heart and Lung Transplantation
  • Japanese Association for Thoracic Surgery
  • Japanese Circulation Society
  • Japan Surgical Society
  • New York Society of Thoracic Surgery
  • Society of Thoracic Surgeons
  • Society of University Surgeons

Other Professional Activities

  • Member of the Annals of Thoracic Surgery Editorial Board
  • Member of Graham Travel fellowship committee
  • Co-Chair, Satellite Symposium 3 “Current trends in mechanical assistance: Role of destination therapy” at the annual meeting of the International Society for Heart and Lung Transplantation, San Francisco, USA, 2004
  • Co-Chair, "Featured Research Session" at the annual meeting of the Japanese Circulation Society, Sapporo, Japan, 2002
  • Co-Chair, "More VADs go bad," at the annual meeting of the International Society for Heart and Lung Transplantation, Vancouver, 2001
  • Chair, "A issue in device immunology", at the annual meeting of the World Artificial-Organ, Immunology, and Transplantation, Ottawa, 2001
  • Chair, "Device patient interaction" at the International Heart and Lung Transplantation 3rd Fall Education Meeting, Mechanical Circulatory Support and Replacement II, Anaheim, 2001
  • Guest Editor, Ann Thoracic Surg 71 (suppl); Proceedings of the Fifth International Conference on Circulatory Support Devices For Severe Cardiac Failure. New York, NY, 9/15-17/00

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Languages

  • Japanese

Gender

  • Male

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

POMCO

  • POMCO

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
177 Fort Washington Avenue
Suite 7-435
New York, New York 10032
Phone:
(212) 305-0828
Fax:
(212) 305-2439
Primary

Research

Cardiac and pulmonary transplantation Organ preservation Surgical treatment of atrial fibrillation Vein graft disease after bypass surgery Outcomes of clinical mechanical circulatory support device surgery and heart transplantation

Research Interests

  • Cardiac and pulmonary transplantation.
  • Organ preservation.
  • Surgical treatment of atrial fibrillation.
  • Vein graft disease after bypass surgery.
  • Outcomes of clinical mechanical circulatory support device surgery and heart transplantation.

Clinical Trials

Current clinical trials:

  • HeartMate II bridge to transplant feasibility trial. Study measuring feasibility and safety of implanting a small axial flow left ventricular assist device to treat patients awaiting heart.
  • MicroMed DeBakey VAD bridge to transplant pivotal trial. Study measuring effectiveness of implanting another small axial flow left ventricular assist device to treat patients awaiting heart.
  • MicroMed DeBakey VAD Destination Therapy trial. Study measuring effectiveness of implanting a small axial flow left ventricular assist device to treat patients with chronic end-stage heart failure who are not transplant candidates.
  • Impella feasibility trial. Study measuring feasibility and safety of inserting an minimal invasive small axial flow left ventricular assist device to treat patients in acute cardiogenic shock.

Completed clinical trials:

  • PREVENT-IV trial. Treatment of vein graft disease using E2F decoy in coronary artery bypass graft patients (Enrollment completed).

Grants

HEARTMATE? III - IDE CLINICAL STUDY PROTOCOL (P&S Industry Clinical Trial)

Sep 4 2014 - Sep 4 2019

RANDOMIZED EVALUATION OF VAD INTEVENTION BEFORE INOTROPIC THERAPY (REVIVE-IT) PILOT TRIAL (P&S Industry Clinical Trial)

Dec 13 2013 - Dec 13 2018

A PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SAFETY AND EFFICACY TRIAL OF MULTIPLE DOSING REGIMENS OF ABT-719 FOR THE PREVENTION OF ACUTE KIDNEY INJURY IN SUBJECTS UNDERGOING HIGH RISK CARDIAC SURGERY (P&S Industry Clinical Trial)

May 21 2013 - May 21 2018

AN EVALUATION OF RIGID STERNAL FIXATION IN SUPPORTING BONE HEALING AND IMPROVING POSTOPERATIVE RECOVERY: A PROSPECTIVE, RANDOMIZED TRIAL (P&S Industry Clinical Trial)

Apr 8 2013 - Apr 8 2018

DESTINATION THERAPY STUDY OF THE JARVIK 2000 ADULT LEFT VENTRICULAR ASSIST SYSTEM, POST-AURICUAR CABLE (P&S Industry Clinical Trial)

Feb 1 2013 - Feb 1 2018

ADVANCED FELLOWSHIP IN CIRCULATORY ASSISTANCE AND HEART FAILURE SURGERY (Private)

Jul 1 2016 - Jun 30 2017

FREEDOM DRIVER (P&S Industry Clinical Trial)

Oct 13 2011 - Oct 13 2016

SYCARDIA PMSS (P&S Industry Clinical Trial)

Sep 14 2011 - Sep 14 2016

SAFETY & EFFICACY OF INTGRAMYOCARDIAL INJECTION OF MESSENCHYMAL PRECURSOR CELLS ON MYOCARDIAL FUNCTION IN LVAD RECIPIENTS (Federal Gov)

Dec 15 2014 - Mar 31 2016

NETWORK FOR CARDIOTHORACIC SURGICAL INVESTIGATIONS IN CARDIOVASCULAR MEDICINE (Federal Gov)

Jul 1 2007 - Jan 31 2015

LVAD THERAPY: EXPLORING THE EFFECT OF INTRAMYOCARDIAL INJECTION OF MESENCHYMAL PRECURSOR CELLS ON MY (Federal Gov)

Jul 1 2011 - Sep 30 2013

THORATEC FELLOWSHIP IN CARDIOTHORACIC SURGERY (VAD) (Private)

Jul 1 2009 - Jun 30 2013

THORATEC FELLOWSHIP IN CARDIOTHORACIC SURGERY (Private)

Jul 1 2009 - Jun 30 2012

THORATEC FELLOWSHIP IN CARDIOTHORACIC SURGERY (VAD) (Private)

Jul 1 2009 - Jun 30 2012

PROMOTING INDEPENDENCE THROUGH PAIN AND SYMPTOM MANAGEMENT (Federal Gov)

Jul 1 2011 - May 31 2012

THE BIOLOGY OF HUMAN LONG-TERM MECHANICAL CIRCULATORY SUPPOR T (Federal Gov)

Feb 25 2005 - Dec 31 2011

SURGICAL MANAGEMENT OF HEART FAILURE (Private)

May 1 2011 - Aug 31 2011

Selected Publications

  • Han J, Takeda K, Takayama H, Kurlansky PA, Mauro CM, Colombo PC, Yuzefpolskaya M, Fukuhara S, Truby LK, Topkara VK, Garan AR, Mancini DM, Naka Y.  Durability and clinical impact of tricuspid valve procedures in patients receiving a continuous-flow left ventricular assist device.  J Thorac Cardiovasc Surg. 2016 Feb;151(2):520-527
  • Fukuhara S, Takeda K, Garan AR, Kurlansky P, Hastie J, Naka Y, Takayama H. Contemporary mechanical circulatory support therapy for postcardiotomy shock. Gen Thorac Cardiovasc Surg. 2016  [Epub ahead of print]
  • Fukuhara S, Takeda K, Polanco AR, Takayama H, Naka Y.  Prolonged continuous-flow left ventricular assist device support and posttransplantation outcomes: A new challenge. J Thorac Cardiovasc Surg. 2016. 151(3):872-880
  • Lee M, Akashi H, Kato TS, Takayama H, Wu C, Xu K, Collado E, Weber MP, Kennel PJ, Brunjes DL, Ji R, Naka Y, George I, Mancini D, Farr M, Christian Schulze P.  Vascular inflammation and abnormal aortic histomorphometry in patients after pulsatile- and continuous-flow left ventricular assist device placement.  J Heart Lung Transplant. 2016 [Epub ahead of print]
  • Wever-Pinzon O, Naka Y, Garan AR, Takeda K, Pan S, Takayama H, Mancini DM, Colombo  P, Topkara VK. National trends and outcomes in devie-related thromboembolic complications and malfunction among heart transplant candidates supported with continuous-flow left ventricular assist devices in the United States. J Heart Lung Transplant. 2016, 35:884-892.
  • Willey JZ, Gavalas MV, Trinh PN, Yuzefpolskaya M, Reshad Gran A, Levin AP, Takeda K, Takayama H, Fried J, Naka Y, Topkara VK, Colombo PC. Outcoms after stroke complicating left ventricular assist device. J Heart Lung Transplant. 2016 Epub
  • Levin AP, Saeed O, Willey JZ, Levin CJ, Fried JA, Patel SR, Sims DB, Nquyen JD, Shin JJ, Topkara VK, Colombo PC, Goldstein DJ, Naka Y, Takayama H, Uriel N, Jorde UP.  Watchful waiting in continuous-flow left ventricular aside device patients with ongoing hemolysis associated with an increased risk for cerebrovascular accident or death.  Circ Heart Fail. 2016, 9 Epub
  • Sorabella RA, GuglieimettiL, Bader A, Gomez A, Takeda K, Chai PJ, Takayama H, Bacha EA, Naka Y, George I.  The use of hypothermic circulatory arrest during heart transplantation does not worsen posttransplant survival. Ann Thorac Surg. 2016 Epub.
  • Topkara VK, Knotts RJ, Jennings DL, Garan AR, Leving AP, Breskin A, Castagna F, Cagliostro B, Yuzefpolskaya M, Takeda K, Takayama H, Uriel N, Mancini DM, Eisenberger A, Naka Y, Colombo PC, Jorde UP. Effect of CYP2C9 and VHORC1 gene variants on warfarin response in patients with continuous-flow left ventricular assist devices (CF-LVADs). ASAIO J 2016 Epub
  • Varr BC, Restaino SW, Farf M, Scully B, Colombo PC, Naka Y, Mancini DM.  Infectious complications after cardiac transplantation in patients bridged with mechanical circulatory suppor devices versus medical therapy. J Heart Lung Transplant. 2016 Epub
  • Coromilas E, Que-Xu EC, Moore D, Kato TS, Wu C, Ji R. Givens R, Jorde UP, Takayama H, Naka Y, Goerge I, Mancini D, Schulze PC.  BMC Cardiovasc Disord. 2016. 14;16:138
  • Weerahandi H, Goldstein N, Gelfman LP, Jorde U, Kirkpatrick JN, Marble J, Naka Y, Pinnery S, Slaughter MC, Bagiella E, Ascheim DD. J Pain Symptom Manage. 2016. Epub
  • Topkara VK, Garan AR, Fine B, Godier-Furnemont AF, Breskin A, Cagliostro B, Yuzefpolskaya M, Takeda K, Takayama H, Mancini DM, Naka Y, Colombo PC. Myocardial recovery in patients receiving contemporary left ventricular assist devices: Results from the interagency registry for mechanically assisted circulatory support (INTERMACS). Circ Heart Fail. 2016. Epub
  • Ton VK, Garan AR, Takeda K, Takayama H, Naka Y.  LVAD implantation following repair of acute postmyocardial infarction ventricular septal defect.  J Card Surg. 2016. Epub.
  • Fukuhara S, Takeda K, Blair A, Kurlansky PA, Takayama H, Naka Y. Posttransplant outcomes among septagenarians bridged to transplantation with continuous-flow left ventricular assist devices.   Ann Thorac Surg Epub
  • Clerkin KJ, Naka Y, Mancini DM, Colomba PC, Topkara VK. The impact of obesty on patients bridged to transplantation with continuous flow left ventricular assist devices. JACC Heart Fail Epub
  • Vest AR, Kennel PJ, Madonad D, Young JB, Mountis MM, Naka Y, Colombo PC, Mancini DM, Starling RC, Schulze PC. Recovery serum cholesterol predicts survival after left ventricular assist device implantation .  Circ Heart Fail Epub
  • Cagliostro B, Levin AP, Fried J, Stewart S, Parkis G, Mody KP, Garan AR, Topkara V, Takayama H, Naka Y, Jorde UP, Uriel N.  Continuous-flow left ventricular assist devices and usefulness of a standardized strategy to reduce drive-line infections.  J Heart Lung Transplant. 2016. 35:108-114.
  • Levin AP, Jaramillo N, Garan AR, Takeda K, Takayama H, Yuzefpolskaya M, Mancini DM, Naka Y, Colombo PC, Topkara VK.  Outcomes of contemporary mechanical circulatory support device configurations in patients with severe biventricular failure. J Thorac Cardiovasc Surg. 2016 Feb;151(2):530-535
  • Fukuhara S, Takeda K, Chiuzan C, Han J, Polanco AR, Yuzefpolskaya M, Mancini DM, Colombo PC, Topkara VK, Kurlansky PA, Takayama H, Naka Y.  Concomitant aortic valve repair with continuous-flow left ventricular assist devices: Results and implications.  J Thorac Cardiovasc Surg. 2016 Jan;151(1):201-210.
  • Sorabella RA, Guglielmetti L, Kantor A, Castillero E, Takayama H, Schulze PC, Mancini D, Naka Y, George I.  Cardiac Donor Risk Factors Predictive of Short-Term Heart Transplant Recipient Mortality: An Analysis of the United Network for Organ Sharing Database.  Transplant Proc. 2015 Dec;47(10):2944-51.
  • Sorabella RA, Mamuyac E, Yerebakan H, Najjar M, Choi V, Takayama H, Naka Y, Argenziano M, Smith CR, George I.  Residual Tricuspid Regurgitation following Tricuspid Valve Repair during Concomitant Valve Surgery Worsens Late Survival.  Heart Surg Forum. 2015 Nov 24;18(6):E226-31
  • Yuzefpolskaya M, Uriel N, Flannery M, Yip N, Mody K, Cagliostro B, Takayama H, Naka Y, Jorde UP, Goswami S, Colombo PC. Advanced cardiovascular life support algorithm for the management of the hospitalized unresponsive patient on continuous flow left ventricular assist device support outside the intensive care unit.  Eur Heart J Acute Cardiovasc Care. 2015 Epub
  • Takayama H, Landes E, Truby L, Fujita K, Kirtane AJ, Mongero L, Yuzefpolskaya M, Colombo PC, Jorde UP, Kurlansky PA, Takeda K, Naka Y. Feasibility of smaller arterial cannulas in venoarterial extracorporeal membrance oxygenation. J Thorac Cardiovasc Surg. 2015 Epub.
  • Farr , Mitchell J, Lippel M, Kato TS, Jin Z, Ippolito P, Dove L, Jorde UP, Takayama H, Emond J, Naka Y, Mancini D, Lefkowitch JH, Schulze PC. Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advance heart failure and suspected liver dysfunction.  J Heart Lung Transplant 34: 873-82, 2015
  • Aldehali A, Esmailian F, Deng M, Soltesz E, Hsich E, Naka Y, Mancini D, Camacho M, Zucker M, Leprince P, Padera R, Kabashigawa J; PROCEED II trial investigators. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicenter, randomized non-inferiority tiral. Lancet 385:2577-2584, 2015
  • Dionizovik-Dimanovski M, Levin AP, Fried J, Mody KP, Simonich E, Garan AR, Yuzefpolskaya M, Takayama H, Naka Y, Colombo PC, Kalesan B, Uriel N, Jorde UP. ASAIO J 61:386-390, 2015
  • Takeda K, Takayama H, Colombo PC, Yuzefpolskaya M, Fukuhara S, Han J, Kurlansky P, Mancini DM, Naka Y. Incidence and clinical significance of late right heart failure during continuous-flow left ventricular assist device support. J Heart Lung Transplant. 34:1024-1032, 2015
  • Castillero E, Akashi H, Pendrak K, Yerebakan H, Najjar M, Wang C, Naka Y, Mancini DM, Sweeney HL, D’Armiento JM, Ali ZA,  Schulze PC, George I. Attenuation of the unfolded protein response and endoplasmic reticulum stress after mechanical unloading in dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2015 Epub.
  • Uriel N, Levin aP, Sayer GT, Mody KP, Thomas SS, Adatya S, Yuzefposkaya M, Garan AR, Breskin A, Takayama H, Colombo PC, Naka Y, Burkhoff D, Jorde UP. Left ventricular decompression during speed optimization ramps in patients supported by CF-LVADS: Device specific performance characteristics and impact for diagnostic algorithms. J Card Fail. 2015 Epub
  • Truby L, Mundy L, Kelesan B, Kirtane A, Colombo PC, Takeda K, Fukuhara S, Naka Y, Takayama H.  Contemporary outcomes of venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock at a large tertially care center.  ASAIO J 2015 Epub.
  • Garan AR, Levin AP, Topkara V, Thomas SS, Yusefposckaya M, Colombo PC, Takeda K, Takayama H, Naka Y, Wang W, Jorde UP, Uriel N. Early post-operative ventricular arrhythmias in patients with continuous-flow left ventricular assist devices.  J Heart Lung Transplant.  2015 Epub
  • Ota T, Yerebakan H, Neely RC, Nogero L, George I, Takayama H, Williams MR, Naka Y, Argenziano M, Bacha E, Smith CR, Stewart AS. Short-term outcomes in adult cardia surgery in the use of del Nido cardioplegia solution. Perusion. 2015 Epub
  • Tsukashita M, Takayama H, Takeda K, Han J, Colomboa PC, Yuzefpolskaya M, Topkara VK, Garan AR, Mancini DM, Kurlansky PA, Naka Y. Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival. J Thorac Cardiovasc Surg. 2015 Epub
  • Pan S, Sksut B, Wever-Pinzon OE, Rao SD, Levin AP, Garan AR, Fried JA, Takada K, Takayama H, Yuzefpolskaya M, Uriel N, Jorde UP, Mancini DM, Naka Y, Colombo PC, Topkara VK. Incidence and predictors of myocardial recovery on long-term left ventricular assist device support: Results from the united network for organ sharing database.  J Heart Lung Transplant. 2015 Epub
  • Teuteberg JJ, Slaughter MS, Rogers JG, McGee EC, Pagani FD, Gordon R, Rame E, Acker M, Kormos RL, Salerno C, Schleeter TP, Goldstein DJ, Shin J, Starling RC, Wozniak T, Malik AS, Silvestry S, Eward GA, Jorde UP, Naka Y, Birks E, Najarian KB, Hathaway DR, Aaronson KD; ADVANCE Trial Investigators. JACC Heart Fail. 2015. 3:818-828.
  • Yerebakan H, Sorabella RA, Najjar M, Castillero E, Mongero L, Beck J, Hossain M, Takayama H, Williams MR, Naka Y, Argenziano M, Bacha E,  Smith CR, George I. Del Nido cardioplegia can be safely administered in high-risk coronary artery bypass grafting surgery after acute myocardial infarction: a propensity matched comparison. J Cardiothorac Surg. 2014 Epub
  • Levine A, Uriel N, Takayama H, Mody K, Ota T, Yuzefpolskaya M, Colombo P, Garan A, Dionizovik-Dimonovski M, Sladen R, Naka Y, Jorde U. Device exchange in Heart II recipients: long-term outcomes and risk thrombosis recurrence. ASAIO J. 2014 Epub
  • Wever-Pinzon O, Givens RC, Flannery M, Naka Y, Jorde UP. Repetitive HeartMate II pump stoppage induced by transitioning from battery to main power source: The short-to-shield phenomenon. J Heart Lung Transplant. 2014 Epub
  • Takeda Ko, Takayama H, Kalesan B, Uriel N, Colombo PC,  Jorde UP, Yuzefpolskaya M, Mancini DM,  Naka Y. Outcome of cardiac transplantation inn patients requiring prolonged continuous-flow ventricular assist device support. J Heart Lung Transplant. 2015 Epub
  • Clerkin KJ, Thomas SS, Haythe J, Christian Schulze P, Farr M, Takayama H, Jorde UP, Restaino SW, Naka Y, Mancini DM. Mechanical circulatory support as a bridge to cardiac retransplantation: A single center experience.  J Heart Lung Transplant. S1053-2498 (14)1368-0. 2014
  • Truby L, Naka Y, Kalesan B, Ota T, Kirtane AJ, Kodali S, Nikic N, Mundy L, Colombo P, Jorde UP, Takayama H. Important role of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock. Eur J Cardiothorac Surg. Pil: ezu 478. 2014
  • Sorabella RA, Yerebakan H, Walters R, Takada K, Colombo P, Yuzefpolskaya M, Jorde U, Mancini D, Takayama H, Naka Y. Comparison of outcomes after heart replacement therapy in patients over 65 years old. Ann Thorac Surg. 99: 582-588, 2014.
  • Martin ST, Kato TS, Farr M, McKeen JT, Cheema F, Ji M, Ross A, Yerebakan H, Naka Y, Takayama H, Restaino S, Mancini D, Schulze PC. Similar survival in patients following heart transplantation receiving induction therapy using Daclizumab vs. Basiliximab.  Circ J. 2014 Epub
  • Takeda K, Takayama H, Colombo PC, Jorde UP, Yuzefpolskaya M, Fukuhara S, Mancini DM, Naka Y. Late right heart failure during support with continuous-flow left ventricular assist devices adversely affects post-transplant outcome. J Heart Lung Transnplant. 2014 pii: S1053-2498(14)01426-0
  • Wasson LT, Yuzefpolskaya M, Wakabayashi M, Takayama H, Naka Y, Uriel N, Jorde UP, Demmer RT, Colombo PC. Heart Fail Rev. Epub, 2014.
  • Takeda K, Takayama H, Kalesan B, Uriel N, Colombo PC, Jorde UP, Naka Y. Long-term outcome of patients on continuous-flow left ventricular assist device suppot. J Thorac Cardiovasc Surg. 148: 1606-1614, 2014.
  • Landes E, Naka Y, Takeda K, Takayama H. Single center experience with a minimally invasive apicoaxillary external left ventricular assist device. J Thorac Cardiovasc Surg. 2014. Epub.
  • Kato TS, Lippel M, Naka Y, Mancini DM, Schulze PC. Post-transplant survival estimation using pre-operative albumin levels. J Heart Lung Transplant 2014. 33:547-548.
  • Fried J, Han J, Naka Y, Jorde UP, Uriel N. Myocardial infarction after left ventricular assist device implantation: clinical course, role of aortic root thrombus, and outcomes. J Heart Lung Transplant. 2014. 33:112-115.
  • John R, Naka Y, Park SJ, Sai-Sudhakar C, Salerno C, Sundareswaran KS, Farrar DJ, Milano CA. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices. J Thoratec Cardiovasc Surg. 2014. 147:581-589.
  • Khawaja T, Chokshi a, Ji R, Kato TS, Xu K, Zizola C, Wu C, Forman DE, Ota T, Kennel PJ, Takayama H, Naka Y, George I, Mancini D, Schulze PC. Erratum to: ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failure. J Cachexia Sarcopenia Musle 2014. Epub.
  • Khawja T, Chokshi A, Ji R, Kato TS, Xu K, Zizola C, Wu C, Forman DE, Ota T, Kennel P, Takayama H, Naka Y, George I, Mancini D, Schulze CP. Ventricular assiste device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failure. J Cachexia Sarcopenia Muscle. 2014. Epub.
  • Fried J, Levin AP Mody KM, Garan AR, Yuzefpolskaya M, Takayama H, Diuguid DL, Naka Y, Jorde U, Uriel N. Prior hematologic conditions carry a high morbidity and mortality in patients supported with continuous flow left ventricular assist devices. J Heart Lung Transplant. 2014 Epub.
  • Pronschinske KB, Qiu S, Wu C, Kato TS, Khawaja T, Takayama H, Naka Y, Templeton DL George I, Farr MA, Mancini DM, Christian Schulze P. Neutrophil gelatinase- associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement. J Heart Lung Transplant. 2014 Epub.
  • Takayama H, Soni L, Kalesan B, Truby LK, Ota T, Cedola S, Khapley Z, Uriel N, Colombo P, Mancini DM, Jorde UP, Naka Y. Bridge-to-decision therapy with a continuous flow external ventricular assist device in refractory cardiogenic shock of various etiologies. Circ Heart Fail. 2014, Epub.
  • Uriel N, Numi N, Colombo PC, Yuzefpolskaya M, Restaino SW, Han J, Thomas SS, Garan AR, Takayama H, Mancini DM, Naka Y, Jorde UP. Advanced heart failure in patients infected with human immunodeficiency virus: Is there equal access to care? J Heart Lung Transplant 2014. Epub.
  • Moazami N, Steffen RJ, Naka Y, Norde U, Bailey S, Murali S, Camacho MT, Zucker M, Marascalco PJ, Rao V, Feldman D; SUSTANI investigators. Lessons learned from the first fully magnetically levitated centrifugal LVAD trial in the United States: The DuraHeart Trial. Ann Thorac Surg 2014. Epub.
  • Thomas SS, Naumi N, Han J, Lippel M, Colombo P, Yuzefpolskaya M, Takayama H, Naka Y, Uriel N, Jorde P. Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score. J Heart Lung Transplant 2014. Epub.
  • Ascheim DD, Gelijns AS, Goldstein D, Moye LA, Smedila N, Lee S, Klodell CT, Szady A, Parides MK, Jeffries NO, Skerrett D, Taylor DA, Rame JE, Milano C, Rogers JG, Lynch J, Dewey T, Eichhorn E, Sun B, Feldman D, Simari R, O’Gara PT, Taddei-Peters WC, Miller MA, Naka Y, Begiella E, Rose EA, Woo YJ. Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices. Circulation 2014. 129:2287-2296.
  • Kato TS, Jiang J, Schulze PC, Jorde U, Uriel N, Kitada S, Takayama H, Naka Y, Mancinic D, Gillam L, Homma S, Farr M. Serial echocardiography using tissue Doppeler and speckle tracking imaging to monitor right ventricular failure before and after left ventricular assist device surgery. JACC Heart Fail. 2013. 1: 216-222.
  • Garan AR, Iyer V, Whang W, Mody KP, Yuzefpolskaya M, Colombo PC, Te-Frey R, Takayama H, Naka Y, Garan H, Jorge UP, Uriel N. Catheter ablation for ventricular tachyarrhythmias in patients supported by continuous flow left ventricular assist devices. ASAIO J. 2014. Epub.
  • Jorde UP, Kushwaha SS, Tatooles AJ, Naka Y, Bhat G, Long JW, Horstmanshof DA, Kormos RL, Teuteberg JJ, Slaughter MS, Birks EJ, Farrar DJ, Park SJ; HeartMate II Clinical Investigators. Results of the destination therapy post-FDA-approval study with a continuous flow left ventricular assist device: A prospective study using the INTEWMACS Registry. J Am Coll Cardiolol. 2014. Pii:S0735-1097.
  • Morrison KA, Jorde UP, Garan AR, Takayama H, Naka Y, Uriel N. Acquired von Willebrand disease during CentriMag support is associated with high prevalence of bleeding during support and after transition to heart replacement therapy. ASAIO J. 2014. 60: 241-242.
  • Chung CJ, Wu C, Jones M, Kato TS, Dam TT, Givens R, Templeton DL, Maurer MC, Naka Y, Takayama H, Mancini DM, Schulze PC. Reduced handgrip strength as a marker of frailty predicts clinical outcomes in patients with heart failure undergoing ventricular assist device placement. J Card Fail. 2014. Pii: S1071-9164.
  • Mody KP, Takayama H, Landes E, Yuzefpolskaya M, Colombo PC, Naka Y, Jorde UP, Uriel N. Acute mechanical circulatory support o fulminant myocardiogenic shock. J Cardiovasc Transl Res. 201. 7:156-64.
  • Nishimura T, Ota T, Takayama H, Naka Y. Extended trans-septal and left atrial dome incision combined with Manouguian’s aortotomy for complex double valve surgery. Eur J Cardiothoracic Surg. 2014. Epub.
  • Jorde UP, Uriel N, Nahumi N, Bejar D, Gonzalez-Constello J, Thomas SS, Han J, Morrison KA, Jones S, Kodali S, Hahn RT, Shames S, Yuzefpolskaya M, Colombo P, Takayama H, Naka Y. Prevalence, significance, and management of aortic insufficiency in continuous flow left ventricular assist device recipients. Circ Heart Fail. 2014. Epub.
  • Uriel N, Han J, Morrison KA, Naumi N, Yuzefpolskaya M, Garan AR, Duong J, Colombo PC, Takayam H, Thomas S, Naka Y, Jorde UP. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: A multifactorial phenomenon. J Heart Lung Transplant. 2013. Epub.
  • Takeda K, Naka Y, Yang JA, Uriel N, Colombo PC, Jorde UP, Takayama H. Timing of temporary right ventricular assist device insertion for severe right heart failure after left ventricular assist device implantation. ASAIO J. 2013. 59:564-569
  • Wang DY, Kelly LA, Richmond ME, Quinn TA, Cheng B, Spotnitz MD, Cabreriza SE, Naka Y, Stewart AS, Smith CR, Spotnitz HM. Feasibility of temporary biventricular pacing after off-pump coronary artery bypass grafting in patients with reduced left ventricular function. Tex Heart Inst J. 2013: 40: 403-409.
  • Kato TS, Colombo PC, Nahumi N, Kitada S, Takayama H, Naka Y, Di Tullio MR, Homma S, Mancini D, Jorde UP, Uriel N. Value of serial echo-guided rump studies in a patient with suspicion of device thrombosis after left ventricular assist device implantation. Echocardiography. 2013. Epub.
  • Bartoli CR, Demarest CT, Khalpey Z, Takayama H, Naka Y. Current management of left ventricular assist device erosion. J Card Surg 2013. Epub.
  • Ota T, Yerebakan H, Akashi H, Takayama H, Uriel N, Colombo PC, Jorde UP, and Naka Y. Continuous-flow left ventricular assist device exchange: clinical outcomes. J Heart Lung Transplant. 2013. Epub.
  • Takeda K, Naka Y, Yang JA, Uriel N, Colombo PC, Jorde UP, Takayama H. Outcome of unplanned right ventricular assist device support for severe right heart failure after implantable left ventricular assist device insertion. J Heart Lung Transplant. 2013. Epub.

Book Chapters

  • Hill JD, Farrar DJ, Naka Y, Chen JM, Portner PM, Loisance D. Positive Displacement Ventricular Assist Devices. In: Mechanical Circulatory Support. ISHLT Monograph Series. Editors. Frazier OH, and Kirklin JK. Elsevier Saunders. Pp 53-76. 2006.
  • Dang NC, Oz MC, Naka Y. Ventricular Assist. In: Kaiser LR, Kron IL, Spray TL eds. Mastery of Cardiothoracic Surgery. 2nd edition. Lippincott Williams & Wilkins, Philadelphia, Pp 500-509, 2006.
  • Aggarwal S, Cheema F, Oz MC, Naka Y. Long-term Mechanical Circulatory Support. In Cohn LH ed. Cardiac Surgery in the Adult. 3rd edition. McGraw Hill Medical, New York, Pp 1609-1627. 2006.
  • Naka Y, Rose EA. Assisted Circulation in the Treatment of Heart Failure. In Zippes, Libby, Bonow, Mann, eds Braunwald’s Heart Disease 8th ed. Philadelphia, Elsevier Saunders. 2007: pp 685-696.
  • Morgan JA, Oz MC, Naka Y. Ventricular assist devices. In Sellke FW, del Nido PJ, Swanson SJ, eds Sabiston & Spencer Surgery of the Chest. 8th ed. Elsevier Saunders, 2010; pp1507-1524.
  • Sayer G, Naka Y, Jorde UP. Ventricular assist device therapy in advanced heart failure – State of the art. In Jeremias and Brown eds Cardiac Intensive Care 2nd ed. Elsevier Saunders, 2010; pp 576-585.
  • Takayama H, Worku B, Naka Y. Chapter 11. Postoperative Management of the patient with a Ventricular Assist Device. In: Sladen RN, Fanshawe M, editors. A Society of Cardiovascular Anesthesiologists Monograph. Postoperative Cardiac Care. Chapter 11. Wolters Kluwer/Lippincott Williams&Wilkins; 2011, p191-206.
  • Takayama H, Naka Y. HeartMate II. In: Matsuda H, ed. Heart Transplantation. Tokyo, Japan: Springer Japan; 2011: 4.4.5.
  • Takayama H, Worku B, Naka Y. Chapter 66. Long-term Mechanical Circulatory Support. In: Cohn LH editor. Cardiac Surgery in the Adult, 4th edition. McGraw Hill Medical; 2012, p1353-1372.
  • Takayama H, Yang J, Naka Y. Chapter 152. Cardiothoracic Surgery on Patients with Mechanical Circulatory Support Devices. In: Franco KL, Thourani VH, editors. Cardiothoracic Surgery Review. Wolters Kluwer/Lippincott Williams&Wilkins; 2012.
  • Takayama H, Yang J, Naka Y. Chapter 177. Redo Heart Transplantation (Columbia Experience). In: Franco KL, Thourani VH, editors. Cardiothoracic Surgery Review. Wolters Kluwer/Lippincott Williams&Wilkins; 2012.
  • Takayama H, Thomas S, Naka Y. Chapter 6. Transplant versus VAD: Evolving and Future Perspectives. In Shunei Kyo, editor. Ventricular assist devices in advanced-stage heart failure. Springer 2014.

Books

  • Deng M and Naka Y. Mechanical Circulatory Support Therapy in Advanced Heart Failure. 2007. Imperial Press.
  • Morgan J and Naka Y. Surgical Treatment of Advanced Heart Failure. 2013. Springer.